Mainboard · BSE and NSEDraft filed

Rodec Pharma Limited IPO: dates, price band, lot size, objects of the issue

Get updates on this IPO

Dates, price band, allotment and listing notices by email, and new views from SEBI-registered research analysts on InsightPier by email.

Dates, allotment, listing and analyst views. Stop anytime.

By continuing you agree to the Terms and Privacy policy

Updated Sun 15 Nov 2026, 8:04 pm IST · Source: DRHP dated Sun 11 Jan 2026

Key facts

Price band
Not announced
Lot size
Not announced
Lot amount at the upper band
Not announced
Issue size at the upper band
56,50,000 shares (Amount not stated in the draft)
DRHP dated Sun 11 Jan 2026, page 88
Fresh issue
None
DRHP dated Sun 11 Jan 2026, page 1
Offer for sale
56,50,000 shares (Amount not stated in the draft)
DRHP dated Sun 11 Jan 2026, page 88
Bid dates
Not announced
Listing date
Not announced
Risk factors
71
DRHP dated Sun 11 Jan 2026, page 87
Proposed exchanges
BSE and NSE

Timeline (IST)

  1. Draft filedTue 20 Jan 2026 confirmedDRHP dated Sun 11 Jan 2026
  2. OpensDates to be announced
  3. ClosesDates to be announced
  4. AllotmentDates to be announced
  5. Refund and unblockDates to be announced
  6. ListingDates to be announced

Company and promoters

As described in the DRHP

We are engaged in the business of manufacturing of animal feed supplements and marketing veterinary pharmaceutical drugs and animal feed supplements to address healthcare and nutritional requirements of livestock animals for the animal healthcare sector.

DRHP dated Sun 11 Jan 2026, page 30

Promoters

  • 3 individual promoters

DRHP dated Sun 11 Jan 2026, page 30

Shareholding

HoldingBefore the issueAfter the issue
Promoters and promoter group92.40%Not stated in the DRHP
Public7.60%Not stated in the DRHP

DRHP dated Sun 11 Jan 2026, page 114

Financials (restated)

ItemSeptember 30, 2025March 31, 2025March 31, 2024March 31, 2023
Revenue from operations₹62.73 crore₹106.39 crore₹88.42 crore₹71.61 crore
Profit after tax₹9.73 crore₹18.26 crore₹11.04 crore₹5.21 crore
Net worth₹59.96 crore₹50.04 crore₹31.75 croreNot stated in the draft
Total borrowingsNot stated in the draftNot stated in the draftNot stated in the draftNot stated in the draft

DRHP dated Sun 11 Jan 2026, page 94

Who is selling in the offer for sale

Selling shareholderTypeShares offeredAmount at the upper band
Individual shareholderIndividual56,50,000Not announced
Total offer for saleNot stated in the draft

DRHP dated Sun 11 Jan 2026, page 88

Peer comparison (as in the DRHP)

Name of the CompanyFace Value (₹ Per share)Closing Price (₹ Per share)Revenue from Operations for Fiscal 2025 (₹ in million)EPS (₹ Per share) BasicEPS (₹ Per share) DilutedNAV (₹ Per share)P/E RatioRoNW (%) Financial Year 2025
Rodec Pharma Limited*10[●]1,063.938.088.0822.15[●]36.49
Hester Biosciences Limited101560.603,111.0233.8933.89383.9946.058.82
Sequent Scientific Limited2198.5715,513.700.880.8530.78233.614.19
Alembic Pharmaceuticals Limited2799.9566,720.8029.6829.68264.0326.9511.22

Reproduced from the DRHP dated Sun 11 Jan 2026, pages 134 to 135; InsightPier adds no figures

Risk factors

71 total
  1. Depends on a few third-party manufacturers to make its veterinary drug products (DRHP page 35)
  2. Most revenue comes from two segments: veterinary drugs and animal feed supplements (DRHP page 35)
  3. Revenue is concentrated in Uttar Pradesh (DRHP page 35)
  4. A significant share of revenue comes from certain key customers (DRHP page 35)
  5. Manufacturing is at a single facility in Ghaziabad (DRHP page 35)

All 71 risk factors, DRHP pages 35 to 87

Offer document

Research

Research reports on IPOs from SEBI-registered research analysts, published on InsightPier.

Research reports on IPOs from SEBI-registered research analysts